Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.950
+0.060 (3.17%)
Nov 28, 2025, 4:00 PM EST - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $182.58 million as of November 28, 2025. Its market cap has increased by 44.90% in one year.
Market Cap
182.58M
Enterprise Value
144.31M
1-Year Change
44.90%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $182.58M, an increase of 45.81%. That is a compound annual growth rate of 3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 182.58M | 10.26% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | 334.40M | -36.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |